The Latest Nutraceuticals Articles from Streetwise Reports

Pharma Co. Gets First US Patent for Repurposed Drug

  ()
Clinical-stage pharmaceuticals firm Algernon Pharmaceuticals Inc. has been issued a U.S. patent for the treatment of three related diseases with its investigational drug repirinast.

Showing Results: 1 to 1 of 1